Insulin-mediated glucose uptake monitor
First Claim
Patent Images
1. An implantable medical device system comprising:
- an implantable medical device that receives an electrical signal from a heart, wherein the implantable medical device comprises at least one of a pacemaker, a pacemaker-cardioverter-defibrillator, an implantable pressure monitor, an implantable nerve stimulator, an implantable muscle stimulator, an implantable drug delivery device, and an implantable cardiac monitor; and
a processor coupled to the implantable medical device that monitors insulin-mediated glucose uptake as a function of the electrical signal.
0 Assignments
0 Petitions
Accused Products
Abstract
An implanted medical device may detect the onset of impaired glucose tolerance or Type II diabetes. The implanted medical device may have additional functionality. For example, the implanted medical device may be a pacemaker or a pressure monitor, but may also monitor insulin-mediated glucose uptake by processing electrical signals from the heart. An implanted medical device that monitors insulin-mediated glucose uptake may be implanted in a patient who has not been diagnosed with impaired glucose tolerance or Type II diabetes, and may give the patient early warning if these conditions develop.
18 Citations
29 Claims
-
1. An implantable medical device system comprising:
-
an implantable medical device that receives an electrical signal from a heart, wherein the implantable medical device comprises at least one of a pacemaker, a pacemaker-cardioverter-defibrillator, an implantable pressure monitor, an implantable nerve stimulator, an implantable muscle stimulator, an implantable drug delivery device, and an implantable cardiac monitor; and
a processor coupled to the implantable medical device that monitors insulin-mediated glucose uptake as a function of the electrical signal. - View Dependent Claims (2, 3, 4, 5, 6)
-
-
7. A method comprising:
-
receiving a cardiac signal from a heart;
monitoring insulin-mediated glucose uptake by monitoring at least one of a T-wave amplitude in the cardiac signal, a Q-T interval in the cardiac signal and an S-T elevation in the cardiac signal; and
performing at least one of delivering a pacing pulse to the heart, defibrillating the heart, sensing a pressure in the heart, delivering a nerve stimulus, delivering a muscle stimulus, classifying a cardiac rhythm, sensing an activity and sensing a temperature. - View Dependent Claims (8, 9, 10, 11, 12, 13)
-
-
14. A computer-readable medium comprising instructions that cause a processor to:
-
receive a cardiac signal from a heart;
monitor insulin-mediated glucose uptake by monitoring at least one of a T-wave amplitude in the cardiac signal, a Q-T interval in the cardiac signal and an S-T elevation in the cardiac signal; and
cause a device to perform at least one of delivering a pacing pulse to the heart, defibrillating the heart, sensing a pressure in the heart, delivering a nerve stimulus, delivering a muscle stimulus, and classifying a cardiac rhythm. - View Dependent Claims (15, 16, 17, 18, 19)
-
-
20. A method comprising:
-
implanting a sensor in a patient, the patient having not been diagnosed with Type II diabetes prior to the implantation; and
implanting a monitor in the patient, the monitor coupled to the sensor;
wherein the monitor and the sensor cooperate to monitor one of blood glucose and blood insulin. - View Dependent Claims (21, 22, 23)
-
-
24. An implantable medical device system comprising:
-
an implantable medical device means that receives an electrical signal from a heart;
a processor means coupled to the implantable medical device means that monitors insulin-mediated glucose uptake as a function of the electrical signal;
a sensor means that senses the electrical signal and transmits it to implantable medical device means; and
at least one of a monitoring means that receives a signal other than the electrical signal from the heart, a diagnostic means that diagnoses a condition other than insulin-mediated glucose uptake and a therapeutic means that delivers a therapy other than delivery of insulin. - View Dependent Claims (25, 26, 27, 28, 29)
-
Specification